A PHASE 4 MULTICENTER SINGLE-ARM OPENLABEL STUDY TO EVALUATE THE IMPACT OF APREMILAST (CC-10004) ON MRI OUTCOMES IN SUBJECTS WITH PSORIATIC ARTHRITIS



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.